RS54754B1 - Kristalni oblik argininske soli perindoprila, postupak njene proizvodnje i farmaceutske smeše koje je sadrže - Google Patents

Kristalni oblik argininske soli perindoprila, postupak njene proizvodnje i farmaceutske smeše koje je sadrže

Info

Publication number
RS54754B1
RS54754B1 RS20160321A RSP20160321A RS54754B1 RS 54754 B1 RS54754 B1 RS 54754B1 RS 20160321 A RS20160321 A RS 20160321A RS P20160321 A RSP20160321 A RS P20160321A RS 54754 B1 RS54754 B1 RS 54754B1
Authority
RS
Serbia
Prior art keywords
perindopril
crystalline form
arginine salt
preparing
pharmaceutical compositions
Prior art date
Application number
RS20160321A
Other languages
English (en)
Inventor
Gérard Coquerel
Loïc Lefebvre
Jean-Claude Souvie
Pascale Authouart
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37022969&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS54754(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of RS54754B1 publication Critical patent/RS54754B1/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

α kristalni oblik L-argininske soli perindoprila, formule (I):naznačen time što ima sledeće pikove difrakcije X-zrakova praška, koji su izmereni korišćenjem difraktometra sa bakarnom antikatodom i uz Kβ (Ni) filter i, koji su izraženi kao Braggov ugao 2 teta (°): 4.5, 7.9 i 13.5.Prijava sadrži još 11 patentnih zahteva.
RS20160321A 2006-02-28 2007-02-26 Kristalni oblik argininske soli perindoprila, postupak njene proizvodnje i farmaceutske smeše koje je sadrže RS54754B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0601748A FR2897866B1 (fr) 2006-02-28 2006-02-28 Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
EP07731039.9A EP1989182B1 (fr) 2006-02-28 2007-02-26 Forme cristalline du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
PCT/FR2007/000335 WO2007099217A1 (fr) 2006-02-28 2007-02-26 FORME CRISTALLINE α DU SEL D'ARGININE DU PERINDOPRIL, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT

Publications (1)

Publication Number Publication Date
RS54754B1 true RS54754B1 (sr) 2016-10-31

Family

ID=37022969

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20160321A RS54754B1 (sr) 2006-02-28 2007-02-26 Kristalni oblik argininske soli perindoprila, postupak njene proizvodnje i farmaceutske smeše koje je sadrže

Country Status (28)

Country Link
US (1) US7846961B2 (sr)
EP (1) EP1989182B1 (sr)
JP (1) JP5255454B2 (sr)
KR (2) KR20120001818A (sr)
CN (1) CN101389603B (sr)
AU (1) AU2007220435B2 (sr)
BR (1) BRPI0708278B8 (sr)
CA (1) CA2644467C (sr)
CY (1) CY1117753T1 (sr)
DK (1) DK1989182T3 (sr)
EA (1) EA014716B1 (sr)
ES (1) ES2581982T3 (sr)
FR (1) FR2897866B1 (sr)
GE (1) GEP20125433B (sr)
HK (1) HK1129669A1 (sr)
HR (1) HRP20160644T1 (sr)
HU (1) HUE027898T2 (sr)
MA (1) MA30276B1 (sr)
ME (1) ME02456B (sr)
MY (1) MY151035A (sr)
NO (1) NO20083535L (sr)
NZ (1) NZ570367A (sr)
PL (1) PL1989182T3 (sr)
RS (1) RS54754B1 (sr)
SI (1) SI1989182T1 (sr)
UA (1) UA89905C2 (sr)
WO (1) WO2007099217A1 (sr)
ZA (1) ZA200807024B (sr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009157018A2 (en) 2008-06-24 2009-12-30 Matrix Laboratories Ltd Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof
AU2009212902A1 (en) 2008-09-03 2010-03-18 Apotex Pharmachem Inc. Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
FR2985512B1 (fr) * 2012-01-05 2014-06-20 Servier Lab Procede de preparation du sel de l-arginine du perindopril
FR2985511B1 (fr) * 2012-01-05 2014-01-03 Servier Lab Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN103172696B (zh) * 2012-12-19 2014-12-17 宁波美诺华药业股份有限公司 一种γ晶型的培哚普利精氨酸盐的制备方法
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules
SI26268A (sl) 2021-11-18 2023-05-31 Zupet Rok Postopek za pripravo hidratirane oblike perindopril l-arginina
CN114149357B (zh) * 2021-12-29 2024-06-25 江苏嘉逸医药有限公司 一种γ晶型培哚普利精氨酸盐的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
FR2897865B1 (fr) 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
WO2009157018A2 (en) 2008-06-24 2009-12-30 Matrix Laboratories Ltd Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof

Also Published As

Publication number Publication date
ES2581982T3 (es) 2016-09-08
HRP20160644T1 (hr) 2016-07-01
NZ570367A (en) 2011-03-31
JP5255454B2 (ja) 2013-08-07
AU2007220435A1 (en) 2007-09-07
SI1989182T1 (sl) 2016-07-29
FR2897866A1 (fr) 2007-08-31
US7846961B2 (en) 2010-12-07
KR20120001818A (ko) 2012-01-04
KR20080106948A (ko) 2008-12-09
ZA200807024B (en) 2010-04-28
CA2644467C (fr) 2011-07-26
CN101389603A (zh) 2009-03-18
PL1989182T3 (pl) 2016-09-30
BRPI0708278B8 (pt) 2021-05-25
HK1129669A1 (sr) 2009-12-04
CN101389603B (zh) 2012-07-04
US20090203758A1 (en) 2009-08-13
NO20083535L (no) 2008-08-14
BRPI0708278B1 (pt) 2021-03-02
ME02456B (me) 2017-02-20
EA200801777A1 (ru) 2009-02-27
GEP20125433B (en) 2012-03-26
AU2007220435B2 (en) 2010-11-04
UA89905C2 (ru) 2010-03-10
EA014716B1 (ru) 2011-02-28
EP1989182B1 (fr) 2016-04-13
MY151035A (en) 2014-03-31
MA30276B1 (fr) 2009-03-02
CA2644467A1 (fr) 2007-09-07
CY1117753T1 (el) 2017-05-17
WO2007099217A1 (fr) 2007-09-07
DK1989182T3 (en) 2016-07-25
BRPI0708278A2 (pt) 2011-05-24
HUE027898T2 (en) 2016-10-28
JP2009534295A (ja) 2009-09-24
FR2897866B1 (fr) 2008-04-18
EP1989182A1 (fr) 2008-11-12

Similar Documents

Publication Publication Date Title
RS54754B1 (sr) Kristalni oblik argininske soli perindoprila, postupak njene proizvodnje i farmaceutske smeše koje je sadrže
UA83720C2 (ru) Кристаллическая форма v агомелатина, способ ее получения и фармацевтическая композиция, которая ее содержит
JO3178B1 (ar) النموذج السادس البلوري الجديد من مركب الاغوميلاتين وطريقة تحضيره وتحضير المركبات الصيدلانية المحتوية عليه
UA83718C2 (ru) Кристаллическая форма iv агомелатина, способ ее получения и фармацевтическая композиция, которая ее содержит
GEP20094576B (en) New cyrstalline form iii of agomelatine, a process for its preparation and pharmaceutical compositions containing it
RU2009131727A (ru) Макроциклические полиморфы, композиции, содержащие такие полиморфы, и способы их применения и получения
MY143557A (en) Beta-crystalline form of perindopril arginine salt, process for its preparation, and pharmaceutical compositions containing it
EA200600323A1 (ru) γd-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ
HRP20230813T1 (hr) Upadacitinib solni spoj i postupak njegove pripreme
MX2012013332A (es) Preparacion de intermediarios de posaconazol.
EA201000434A1 (ru) Сокристаллы пириметанила и дитианона
MY147951A (en) Crystalline potassium salt of lipoxin a? analogs
RS53001B (sr) Delta kristalni oblik argininske soli perindoprila, postupak za njegovu proizvodnju i farmaceutske smeše koje ga sadrže
EA200900936A1 (ru) Аморфные и кристаллические формы ривастигмина гидротартрата
WO2009000909A8 (en) Salts of perindopril
JO2959B1 (en) Mono-hydrochloric salts for histone dacetylase inhibitor
MY138209A (en) New (y) crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it.
TNSN05076A1 (en) New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
GEP20094652B (en) New cyrstalline form v of agomelatine, a process for its preparation and pharmaceutical compositions containing it
TH87172B (th) ผลึกรูปแบบ v ชนิดใหม่ของอะโกเมลาทีน, กรรมวิธีในการเตรียมและองค์ประกอบทางเภสัชกรรมซึ่งมีสารนี้
EA026329B1 (ru) НОВАЯ ПОЛИМОРФНАЯ МОДИФИКАЦИЯ ДИОСГЕНИЛ-α-L-ПИРАНОЗИЛ-(1->2)-β-D-ГЛЮКОПИРАНОЗИДА